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During preimplantation mouse development, the
inner cell mass (ICM) differentiates into two cell
lineages—the epiblast and the primitive endoderm
(PrE)—whose precursors are identifiable by recip-
rocal expression of Nanog and Gata6, respectively.
PrE formation depends on Nanog by a non-cell-
autonomous mechanism. To decipher early cell-
and non-cell-autonomous effects, we performed a
mosaic knockdown of Nanog and found that this is
sufficient to induce a PrE fate cell autonomously.
Strikingly, in Nanog null embryos, Gata6 expression
is maintained, showing that initiation of the PrE
program is Nanog independent. Treatment of Nanog
null embryos with pharmacological inhibitors re-
vealed that RTK dependency of Gata6 expression
is initially direct but later indirect via Nanog repres-
sion. Moreover, we found that subsequent expres-
sion of Sox17 and Gata4—later markers of the
PrE—depends on the presence of Fgf4 produced
by Nanog-expressing cells. Thus, our results reveal
three distinct phases in the PrE differentiation
program.
INTRODUCTION
Preimplantation development in the mouse is characterized by
the differentiation of two extraembryonic lineages, the trophec-
toderm and primitive endoderm (PrE), and of a pluripotent cell
population, the epiblast, that gives rise to the embryo proper.
Positional signals via the Hippo pathway direct outer cells of
the late morula to form the trophectoderm, which surrounds
the inner cell mass (ICM) after blastocyst formation (Nishioka
et al., 2009). The mechanisms governing PrE and epiblast
lineage segregation within the ICM remain less understood but
are known to involve a progressive emergence of differential
gene expression in their respective precursors followed byDevelopmentaa combination of cell sorting and cell death (Gerbe et al., 2008;
Meilhac et al., 2009; Plusa et al., 2008). By the time of implanta-
tion at embryonic stage (embryonic day [E]) E4.5, the PrE is a
morphologically distinct epithelium separating the epiblast
from the blastocyst cavity and expresses markers such as
Gata6, Gata4, Sox17, and Pdgfra (Chazaud et al., 2006; Morris
et al., 2010; Niakan et al., 2010; Plusa et al., 2008). Gata6 has
also been shown to be required for PrE epithelium formation
(Cai et al., 2008). Expression of the homeobox transcription
factor Nanog is specific to the early epiblast but subsequently
downregulated after implantation (Chambers et al., 2003).
Nanog appears to be crucial for cells to attain a state of pluripo-
tency that is characteristic of embryonic stem cells (ESCs),
which are considered to be most similar to the early ‘‘naive’’
epiblast of the late preimplantation conceptus (Nichols et al.,
2009). In the embryo, Nanog is required for formation of both
epiblast and PrE cell lineages at E4.5 (Messerschmidt and
Kemler, 2010; Silva et al., 2009). Moreover, blastocyst comple-
mentation experiments with wild-type ESCs gave evidence of
a non-cell-autonomous requirement for Nanog in visceral endo-
derm formation (Messerschmidt and Kemler, 2010). Recent and
earlier studies suggest that Fgf4 could be the non-cell-autono-
mous factor required for PrE differentiation (Arman et al., 1998;
Cheng et al., 1998; Feldman et al., 1995; Goldin and Papaioan-
nou, 2003; Yamanaka et al., 2010). Indeed, transcriptional
profiling of single ICM cells revealed that Fgf4 is expressed at
E3.5 only in pre-epiblast cells (Guo et al., 2010; Kurimoto et al.,
2006). Moreover, Fgf4 administration in embryo cultures drives
ICM cells toward a PrE fate (Yamanaka et al., 2010), whereas
receptor tyrosine kinase (RTK)/Mek pathway inhibition (Nichols
et al., 2009; Yamanaka et al., 2010) or inactivation through
Grb2 knockout (Chazaud et al., 2006) prevents PrE differentia-
tion and induces pan-ICM Nanog expression.
During late morula and early blastocyst stages, expression of
Nanog is widespread and overlapping with expression of Gata6
and Pdgfra (Plusa et al., 2008). By E3.75 (64 cells), expression
of Nanog and PrE markers is largely mutually exclusive, marking
epiblast and PrE precursors, respectively. Expression of Gata4
or Sox17 is initiated later than Gata6, marking cells that subse-
quently sort to form the PrE layer lining the blastocyst cavity.
The mechanisms by which ICM cells interact to establish thel Cell 21, 1005–1013, December 13, 2011 ª2011 Elsevier Inc. 1005
Figure 1. PrE Markers Are Induced in Nanog Knockdown Cells
(A and A0 ) Five-color labeling of 37 hr cultured embryos electroporatedwith control (A) or shNanog (A0) vectors. Arrowheads indicate GFP-positive cells in the ICM.
(B) Histogram showing the percentage of Nanog- and Gata6-positive cells among GFP-positive/Cdx2-negative cells in 37 hr cultured embryos (*p < 0.05,
Wilcoxon test; error bars, SEM).
(C) Histogram showing the distribution of Nanog- and Sox17- or Gata4-positive cells among GFP-positive/Cdx2 negative cells. Embryos labeled for Sox17 were
cultured for 37 hr, whereas for Gata4 labeling, a 45-hr culture was necessary to obtain sufficient numbers of labeled cells.
See also Figure S1.
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to involve mutual inhibition between Nanog and Gata6 as well
as phosphorylation of Erk (p-Erk) downstream of Fgf4 and
Fgfr2 (Chazaud et al., 2006; Nichols et al., 2009; Singh et al.,
2007; Yamanaka et al., 2010).
In this study, we examined the role of intercellular interactions
in the establishment of epiblast and PrE precursors. We show
that knocking down Nanog expression within a random subset
of cells of the late morula is sufficient to enable induction of
a PrE fate. By examining the development of Nanog mutant
conceptuses, we also found that maturation of PrE precursors,
characterized by Gata4 and Sox17 expression, is dependent
on a non-cell-autonomous requirement for Nanog mediated by
Fgf4 signaling. Finally, we found that early expression of Gata6
depends directly on p-Erk, whereas at later stages an absence
of Nanog appears to be sufficient. Ultimately, absence of both
Nanog and p-Erk, in the presence of Gata6, results in cell death.
RESULTS
Nanog Knockdown Is Sufficient to Induce Primitive
Endoderm Formation in Targeted Cells
To analyze cell- and non-cell-autonomous effects at early
stages, we inactivated Nanog by a mosaic RNAi knockdown in
wild-type embryos. This strategy allows knockdown of the
gene within the embryo before cell commitment, in contrast to
embryo complementation assays using ESCs that are already
committed to epiblast.1006 Developmental Cell 21, 1005–1013, December 13, 2011 ª2011To introduce double-stranded RNA into cells, we performed
embryo electroporation (Grabarek et al., 2002; Keramari et al.,
2010; Soares et al., 2005) using expression plasmids. We used
shRNAs to targetNanog, and the progeny of electroporated cells
was identified by H2B-EGFP fluorescence. We used eight-cell
stage embryos to achieve knockdown in progeny ICM cells
because mainly surface cells are electroporated. Moreover,
this stage is well before epiblast and PrE determination occurs,
providing sufficient time for the treatment to potentially influence
cell fate. After electroporation, embryos were cultured to the
equivalent of E4.0–E4.5, when most ICM cells express either
Nanog or Gata6 (Guo et al., 2010; Plusa et al., 2008). Fluores-
cence immunohistochemistry followed by five-channel confocal
microscopy was then performed to detect GFP, Nanog, Gata6
(or other PrEmarker), Cdx2, and nuclei in each embryo. ICMcells
were identified by absence of Cdx2 protein because expression
of Nanog or Gata6 can persist in the trophoblast after blastocyst
formation (Dietrich and Hiiragi, 2007).
Although in control electroporated embryos, GFP-expressing
cells were distributed in both of the ICM cell lineages (Figures
1A and 1B), electroporation of shNanog induced a knockdown
of Nanog in GFP-expressing cells and activated Gata6 expres-
sion (Figures 1A0 and 1B; see Figure S1 available online). There
was no statistically significant difference in the sorting of the
Gata6-expressing cells that were transfected or not (data not
shown). This result suggests a diversion toward PrE fate;
however, Gata6 upregulation might only reflect a release of
Nanog repression, and not a full PrE differentiation program.Elsevier Inc.
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markers, was also examined (Figure 1C). Gata6 is expressed
earlier than Sox17 and Gata4, with Sox17 expressed slightly
earlier than Gata4 (Artus et al., 2011; Morris et al., 2010; Niakan
et al., 2010; Plusa et al., 2008). The number of GFP-positive cells
expressing Sox17 and Gata4 increased when Nanog was
knocked down. Most of the electroporated cells were positioned
at the surfaceof the ICM (17of 20); however, someof themdidnot
express these proteins, suggesting that they might not represent
fully mature PrE. Indeed, a difference can be seen in the number
of Sox17- and Gata4-expressing cells compared with Gata6-
expressing cells, regardless ofNanog knockdown, that probably
reflects their later onset of expression. Such cells without Nanog
and Gata4 expression can also be found quite late in freshly
dissected embryos (Plusa et al., 2008; data not shown). To our
current knowledge, it is not clear whether these cells will eventu-
ally express Sox17 and Gata4, undergo apoptosis (Plusa et al.,
2008), or both.Unfortunately, cleavedcaspase-3or TUNELstain-
ing does not allow identification of cells in combination with tran-
scription factor expression because these methods identify cells
in late apoptosis after the nucleus has usually already degener-
ated. In conclusion, these electroporation experiments demon-
strate that a mosaic knockdown of Nanog cell autonomously
induces expression of Gata6, Sox17, and Gata4, implying a full
diversion toward PrE identity.
NanogMutant Embryos Express Gata6 in theWhole ICM
Our results above show that when Nanog expression is impaired
in a subset of cells, they differentiate into PrE. By contrast, no or
very few Gata4-expressing cells are present when whole
embryos are mutant for Nanog (Messerschmidt and Kemler,
2010; Silva et al., 2009), suggesting that the PrE differentiation
pathway is induced but not maintained. Thus, an analysis of
earlier heterozygous and homozygous Nanog mutant embryos
was carried out.We did not observe any difference in the number
of Nanog-expressing cells between wild-type and heterozygous
embryos, suggesting that one copy of the gene is sufficient to
fulfill Nanog function. Because Gata6 and Sox17 are earlier
markers than Gata4 (Niakan et al., 2010; Plusa et al., 2008), their
expression was analyzed in Nanog null embryos from early E3.5.
At E3.5 and E4.0, Gata6 was expressed in all ICM cells (Figures
2A0 and 2B0; n = 10/10 and 3/3, respectively). Thus, as in the
electroporation experiments, Nanog inactivation induces Gata6
expression. As previously published (Messerschmidt and Kem-
ler, 2010; Silva et al., 2009), only a few cells expressed Gata4
at E4.5–E4.75 (n = 4/4). Similarly to Gata4, Sox17 was expressed
in very few cells at E3.75 and E4.5–E4.75 (Figures 2D0 and 2E0;
n = 4/4 and 3/3, respectively). Pdgfra expression was also
strongly impaired inNanogmutants, with only a fewweakly posi-
tive cells at E4.0 and E4.75 (Figure S2A; n = 5/5), whereas Oct4
expression was not affected (Figures 2C0 and 2E0; n = 8/8).
Surprisingly, Gata6 was still expressed in all ICM cells at E4.5–
E4.75 (Figure 2C0; n = 4/5) or in the majority of them (Figure S2B;
n = 1/5), demonstrating that Gata6 expression does not require
Nanog activity, in contrast to Gata4, Sox17, and Pdgfra expres-
sion. Thus, unlike in the electroporation experiments, Gata6 is
not sufficient to induce Sox17 and Gata4 expression. This
suggests that although repression of Nanog is required cell
autonomously to activate Gata6, a non-cell-autonomous factorDevelopmentais required to induce Sox17 and Gata4 expression. In mosaic
shNanog embryos, this is most likely mediated by the neigh-
boring Nanog-expressing cells.
Because the number of pyknotic nuclei is high in E4.5–4.75
mutant embryos (Figure 2C0), we performed TUNEL staining to
analyze cell death. Prolific cell death was observed in all tissues
of mutant embryos at this stage of development (Figure 2E0; n =
5/5; Messerschmidt and Kemler, 2010). To check whether this
wave of apoptosis induced by the absence of Nanog starts
earlier, we analyzed E3.75 embryos. At this stage, previous
reports showed that in wild-type embryos a small subset of cells
undergoes apoptosis during the sorting of epiblast and PrE cells
(Copp, 1978; Handyside and Hunter, 1986; Meilhac et al., 2009;
Morris et al., 2010; Plusa et al., 2008). TUNEL staining showed
that whereas some cells were apoptotic in control littermate
embryos (Figure 2D), apoptosis was absent in E3.75 Nanog
mutant ICMs (Figure 2D0; n = 3/3), suggesting that they are some-
what protected from the normally occurring apoptosis. It was
proposed that in wild-type embryos cell death might occur in
cells expressing both Nanog and Gata6 (Plusa et al., 2008).
Thus, the sole Gata6 expression may prevent ICM cells from
apoptosis at this stage.
Although previously reported (Chen et al., 2009; Silva et al.,
2009), the lack of Nanog did not seem consistently to induce
trophoblast identity. Mosaic Nanog knockdown did not induce
Cdx2 expression in ICM cells, probably due to a late knockdown
but also to the CD1 genetic background. Indeed, we observed
differences analyzing either the mixed 129/B6/CD1 background
embryos issued from Nanog+/ intercrosses compared to the
CD1 embryos. Cdx2 expression in the ICM, although at lower
levels than in trophoblast cells, was not uncommon in wild-
type and heterozygous embryos produced from Nanog+/ inter-
crosses. In Nanog/ embryos, Cdx2-expressing cells could be
observed in many embryos while not in others (n = 6/17), sug-
gesting that an absence of Nanog does not systematically
induce Cdx2 in inner cells.We also found that the ratio of epiblast
to PrE precursor cells was higher in the 129-mixed background,
consistent with a previous report (Batlle-Morera et al., 2008), and
that the mutually exclusive expression of Nanog and Gata6
developed a few hours later. Moreover, the sorting between
epiblast and PrE cells was slower and sometimes not complete
because some Gata6-, Sox17-, and Gata4-expressing cells
could still be observed deep in the ICM of 129-mixed wild-type
and heterozygous embryos at E4.5 (Figure 2C; n = 6). These
effects tended to disappear while backcrossing on the CD1
background. These observations highlight the variability in differ-
entiation of lineage precursors with respect to their proportions
and their positions.
Fgf4 Is Expressed in Epiblast Precursors and Can
Rescue Sox17 and Gata4 Expression in Nanog Mutants
As a secreted factor, Fgf4 is likely to activate PrE differentiation
in a non-cell-autonomous manner. Single-cell RT-qPCR analysis
has shown that Fgf4 transcripts are highly enriched in pre-
epiblast compared to pre-PrE cells (Guo et al., 2010). We
confirmed this finding by in situ hybridization, showing that
Fgf4 expression is restricted to Nanog-positive cells at E3.5
(thus in pre-epiblast cells) and to the epiblast at E4.5 (Figures
3A and 3B). Fgf4 expression was not detected in Nanog mutantl Cell 21, 1005–1013, December 13, 2011 ª2011 Elsevier Inc. 1007
Figure 2. Analysis of PrE Markers in Nanog–/–
Embryos
(A–B0) Nanog, Gata6, and Cdx2 immunolocalization at
E3.5 (A and A0) and E4.0 (B and B0) in control andNanog/
embryos. Arrowheads indicate mitotic cells in which
Gata6 is not nuclear localized.
(C–C0) Expression of Oct4 and Gata6 at E4.5 in control and
Nanog/ embryos. Arrowheads indicate an unsorted
Gata6-expressing cell.
(D–E0) Nanog or Oct4, Sox17, and TUNEL staining in
control and mutant embryos at E3.75 (D and D0) and E4.75
(E and E0).
See also Figure S2.
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was not observed in Nanog knockdown cells (n = 15/16; Fig-
ure S3). Thus, Fgf4 expression depends on the presence of
Nanog.
Therefore, Fgf4 might be the non-cell-autonomous factor
required to induce Sox17 andGata4 expression inNanogmutant1008 Developmental Cell 21, 1005–1013, December 13, 2011 ª2011 Elsevier Inc.embryos. To test this hypothesis, we cultured
embryos from Nanog+/ intercrosses in the pre-
sence or absence of exogenous recombinant
Fgf4. Because Gata6 is already expressed in
Nanog mutant embryos, we speculated that
treating embryos from the early blastocyst
stage (E3.25) to E4.0 should be sufficient to
induce Sox17 and Gata4. Although almost no
cells were expressing Sox17 in Nanog mutants
of the control culture (n = 5/5), most ICM cells
expressed Sox17 in Fgf4-treated mutant
embryos (n = 6/6, 93% of 59 ICM cells) (Figures
3C and 3C0). With this time window treatment,
Gata4 was not detected (n = 3/3). However,
Gata4 expression was detected in Fgf4-treated
Nanog mutant ICM when embryos were
cultured till E4.5 (Figure 3C00; n = 4/4, 80% of
55 ICM cells). Thus, Fgf4 is sufficient to rescue
the non-cell-autonomous requirement for
Nanog to induce Sox17 and Gata4 expression
in PrE precursors.
RTK-Direct and -Indirect Activation
of Gata6 Expression in the ICM
We and others have shown that the RTK
pathway, through p-Erk activation, is required
for Gata6 and PrE gene expression (Chazaud
et al., 2006; Nichols et al., 2009; Yamanaka
et al., 2010), although we were unable to detect
p-Erk expression immunohistochemically at
the blastocyst stage probably due to low and
transient levels (Figure S4). Because Nanog
can bind the Gata6 promoter and repress its
expression (Singh et al., 2007), we wondered
whether RTK activation of Gata6 occurs directly
or only via inhibition of Nanog-mediated repres-
sion (scheme on Figure 4). To remove this
repression, we used Nanog/ embryos and
cultured them with Fgf receptor and Mek inhibitors (Kunath
et al., 2007; Ying et al., 2008). An absence of Gata6 expression
in these embryos would show that Gata6 is directly induced
by the RTK pathway. By contrast, if Gata6 is still expressed in
Nanog/ embryos treated with the inhibitors, this would
suggest that it is solely due to the relief of Nanog-mediated
Figure 4. Gata6 Expression Is RTK Independent in Nanog–/–
Embryos after Blastocyst Formation
Top: scheme representing the two distinct paths of Gata6 activation by RTKs:
direct (red) and indirect (blue).
(A–C0) Control and mutant embryos were cultured in the presence of
PD0325901 and PD173074 from E2.5 to E4.5 (A and A0), from E3.25 to E4.0 (B
and B0), and from E3.25 to E4.5 (C and C0 ), and labeled with Nanog, Gata6, and
Cdx2 antibodies. See also Figure S4.
(D–D00) Cell composition of embryos after different time windows of inhibitor
treatment. Control and mutant embryos were cultured from E2.5 to E4.5 (D),
from E2.75 to E4.5 (D0), and from E3.25 to E4.0 (D00), and stained for Nanog and
Gata6 expression. (*p < 0.05, Wilcoxon test; error bars, SEM).
Figure 3. Fgf4 Treatment Rescues Sox17 and Gata4 Expression in
Nanog–/– Embryos
(A–B0) Fgf4 RNA labeling in wild-type and Nanog/ embryos at E3.75 (A and
A0) and E4.5 (B and B0), and coupled to Nanog immunofluorescence (A). See
also Figure S3.
(C–C00) Nanog/ embryos cultured in the absence (C) or presence (C0 and C00)
of exogenous Fgf4 from E3.25 to E4.0 (C and C0) or E4.5 (C00) and immunola-
beled.
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through different time windows corresponding to the different
phases of Gata6 expression: from E2.5, at the onset of Gata6
expression; fromE2.75, whenGata6 is coexpressedwith Nanog;
and from E3.25, when reciprocal expression of Gata6 andNanog
begins to emerge. When embryos were treated from E2.5 to
E4.5, no Gata6-expressing cells were observed in wild-type or
mutant embryos (Figures 4A, 4A0, and 4D), showing that the
RTK pathway is required directly for the onset of Gata6 expres-
sion. We then treated embryos from E2.75 because it was previ-
ously shown that Nanog and Gata6 are coexpressed in most, if
not all, cells prior to cavitation (Guo et al., 2010; Plusa et al.,
2008). Thus, at this stage, Nanog repression is presumably not
effective. Surprisingly, with this time window treatment, about
27% of ICM cells expressed Gata6 in the mutant embryos (Fig-
ure 4D0). After treatment from E3.25 to E4.0, Gata6 expression
was repressed as previously described in wild-type embryos
(Yamanaka et al., 2010). By contrast, a high proportion of ICM
cells (67%) expressed Gata6 in the mutant embryos (Figures
4B, 4B0, and 4D00). Thus, at this stage, Gata6 expression does
not depend on the RTK pathway when Nanog is absent. This
result means that in wild-type inhibitor-treated embryos, Gata6
repression solely depends on Nanog expression, and not on
the absence of RTK signaling. Interestingly, the different timeDevelopmentawindow treatments reveal that there are progressively more cells
that switch from RTK-direct to RTK-indirect Gata6 expression
and that at E3.25, some cells are still directly activating Gata6
expression by p-Erk.
Some E3.25 wild-type and Nanog mutant embryos were
treated with the RTK pathway inhibitors for a longer period, tilll Cell 21, 1005–1013, December 13, 2011 ª2011 Elsevier Inc. 1009
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very few in number (Figure 4C0; n = 4/5) and expressed Gata6, or
many contained pyknotic nuclei (n = 1/5). This phenotype was
different from that of untreated mutant embryos or treated
wild-type embryos, which still had an ICM at this stage (Figures
2C0 and 4C, respectively). Loss of ICM cells in untreated Nanog
mutant embryos occurs only later because they are present at
E4.5 (Figure 2C0; Figure S3). This shows that in untreated Nanog
mutant embryos, despite undetectable Fgf4 transcript levels, an
RTK activity is present and required for cell survival. Surprisingly,
this precocious cell death was not observed when the mutant
embryos were treated from E2.5 or E2.75 (Figure 4B0; n = 10).
The notable difference between these groups from our results
above is that Gata6 expression is lower or absent in earlier-
treated embryos. Thus, Gata6 expression, in the absence of
Nanog and RTK activity, is associated with earlier cell death.
DISCUSSION
In this study, we characterized the role of Nanog during epiblast
versus PrE determination in E3.5 blastocysts. By using comple-
mentary approaches of either mosaic knockdown or full mutant
embryos, we analyzed cell-autonomous and non-cell-autono-
mous roles for Nanog. Previous studies have shown that
Nanog/ embryos produce very few or no Gata4-expressing
cells (Messerschmidt and Kemler, 2010; Silva et al., 2009),
demonstrating that PrE cells can be induced but in very low
numbers. Here we show that inactivation of Nanog leads to an
upregulation of Gata6 expression in targeted cells of mosaic or
fully inactivated embryos. This implies that Nanog inhibits
Gata6 expression, probably via direct repression on specific
enhancers (Mitsui et al., 2003; Singh et al., 2007). Thus, removing
Nanog primes cells toward a PrE fate. The pan-ICM Gata6
expression in Nanog mutants together with the pan-ICM Nanog
expression in Grb2 mutants (Chazaud et al., 2006) supports the
model of reciprocal inhibition of Nanog and RTK pathways to
induce either epiblast or PrE differentiation.
Unlike in ESCs, where Gata6 expression leads to an upregula-
tion of several PrE genes (Fujikura et al., 2002;Wang et al., 2011),
pan-ICM Gata6 expression is unable to induce efficiently Sox17,
Gata4, or Pdgfra in Nanogmutant embryos. Furthermore, it was
shown that Gata6 overexpression in the embryo does not influ-
ence cell position (Meilhac et al., 2009; Morris et al., 2010).
Thus, Gata6 alone is not sufficient to induce a full PrE identity,
even in a Nanog mutant background, despite the presence of
GATA response elements in cis-regulatory sequences of
Gata4, Sox17, and Pdgfra (Niakan et al., 2010; Wang and
Song, 1996). Thus, another factor is required in parallel with
Gata6 to induce these downstream PrE genes. Consistent with
this, mosaic Nanog knockdown experiments, as well as ESC
chimaera production (Messerschmidt and Kemler, 2010), show
that the presence of Nanog-expressing cells is sufficient to
induce a full PrE identity in a non-cell-autonomous manner.
We demonstrate here that Fgf4, which is a potent PrE inducer
(Yamanaka et al., 2010), is expressed in epiblast precursor cells
and is regulated by Nanog. Moreover, by adding recombinant
Fgf4 to Nanog mutant embryos in culture, we show that Fgf4 is
the factor required to induce Sox17 and Gata4 expression.
Similar to the wild-type embryos, the onset of Gata4 expression1010 Developmental Cell 21, 1005–1013, December 13, 2011 ª2011was later than that of Sox17 in bothNanog knockdown and Fgf4-
rescued mutant embryos. This internal clock could be regulated
by Sox17 andGata6 levels or by some other cofactors. Thus, PrE
formation depends on both Gata6 (Cai et al., 2008) and Fgf4/RTK
signaling pathways.
Studies in ESCs have suggested that Gata6 expression could
be induced by the RTK pathway directly (Wang et al., 2011) or
indirectly via repression of Nanog (Hamazaki et al., 2006). By
inhibiting the RTK pathway during several time windows in
the absence of Nanog, we show that Gata6 has RTK-direct
and -indirect activation phases. Indeed, around the compaction
stage, in both Nanog mutant and wild-type contexts, Gata6
expression requires the RTK pathway, implying that RTK activa-
tion directly induces Gata6 expression. Fgf4 and Fgfr2 are ex-
pressed at high levels from the two-cell and one-cell stage,
respectively (Guo et al., 2010; Wang et al., 2004), and thus can
potentially induce Gata6 directly, whose expression increases
around the eight-cell stage (Guo et al., 2010; Plusa et al.,
2008). Fgf4 mRNA levels are high before the onset of Nanog
expression, suggesting that Fgf4 induction at the two-cell stage
does not depend on Nanog. Indeed, by RT-PCR we did not
observe any difference in Fgf4 expression between wild-type/
heterozygous embryos and Nanog mutants at that stage (data
not shown). Thus, Fgf4 probably induces Gata6 expression at
precavitation stages. Fgf4 expression requires both Sox2 and
Oct4 (Avilion et al., 2003; Keramari et al., 2010; Nichols et al.,
1998; Yuan et al., 1995), with only Sox2 being specifically down-
regulated in PrE precursors (Guo et al., 2010). Therefore, early
Fgf4 expression could potentially be induced by maternally
supplied Sox2 and Oct4.
Later-stage treatment with Fgfr and Mek inhibitors fails to
downregulate Gata6 in a Nanog mutant background, converse
to in wild-type embryos (Nichols and Smith, 2009; Yamanaka
et al., 2010). This shows that the later Gata6 RTK dependency
in wild-type embryos requires Nanog, and thus RTK signaling
must directly repress Nanog. Thus, whereas the RTK pathway
is always necessary for Gata6 expression, it is clearly required
directly for initially inducing Gata6 expression and indirectly for
its maintenance after cavitation. We cannot rule out the possi-
bility that the RTK pathway continues to contribute directly to
Gata6 expression, but the indirect mechanism seems to be
sufficient to maintain Gata6 expression. It is known that Gata6
contains GATA-binding sites in cis (Molkentin et al., 2000);
thus, after an initial induction by the RTK pathway, Gata6 could
self-maintain its expression at high levels in PrE precursors.
Indeed, it was shown that Gata6 expression remains at the
same levels from the eight-cell stage until formation of PrE pre-
cursors, while being lost in epiblast precursors (Guo et al., 2010).
The remaining RTK activity present in untreated Nanog
mutants, revealed by the presence of a few Sox17-, Gata4-, or
Pdgfra-expressing cells, could depend on the early Fgf4 expres-
sion from the two-cell stage. This early expression is indepen-
dent of Nanog expression, which is detected only later. Thus,
low residual Fgf4 expression could explain how a few cells still
express these PrE markers in untreated Nanog mutant embryos
(Figure 3B0; Messerschmidt and Kemler, 2010; Silva et al., 2009).
However, we cannot exclude activation by another RTK
receptor. Also, a striking loss of ICM cells occurred in Nanog
mutants expressing Gata6 but devoid of RTK signaling. Thus,Elsevier Inc.
Figure 5. A Three-StepMechanism for PrE Specifi-
cation
Gata6 expression is initially induced directly by the RTK
pathway (probably by Fgf4, which is present at this stage).
From the morula-blastocyst transition, Gata6 expression
is maintained only in Nanog-deprived cells through an
indirect activation of the RTK pathway. During PrE matu-
ration, Gata6 expression is still maintained indirectly by
the RTK pathway. Conversely, Sox17 and Gata4 expres-
sion requires direct activation by Fgf4, secreted from
epiblast cells. During these steps of PrE differentiation,
cells are not synchronized, revealing heterochrony.
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slightly delay cell death, perhaps until Fgf4 depletion. These
results suggest that the presence of Gata6, in the absence of
Nanog and p-Erk, leads to cell death. Although the levels of
RTK signaling need to be investigated in wild-type and mutant
embryos (Figure S4), it is possible that such a mechanism is
responsible for the wave of cell death that occurs throughout
cell-sorting stages.
Intriguingly, Fgf4, Fgfr2, Nanog, and Gata6 mRNAs are
present at high levels in the same cells from the eight-cell stage
(Guo et al., 2010), whereas the onset of mutually exclusive Gata6
and Nanog expression occurs only around E3.25. This reciprocal
expression occurs first in a few cells and increases throughout
the fourth day postcoitum in the whole ICM (Plusa et al., 2008).
Possibly, the maturation from RTK-direct to RTK-indirect
Gata6 induction results in more stable expression and allows
mechanisms that establish reciprocal expression to operate.
Alternatively, it could be a consequence of these mechanisms.
In our experiments, some inhibitor-treated mutant cells were
already resistant to RTK pathway inhibition at E2.75 (Figure 4D0),
suggesting that this heterochronic maturation initiates quite
early. However, the absence of Nanog repression might have
accelerated the process compared to in wild-type embryos,
perhaps distorting the normal timing of events. The onset of
mutually exclusive Gata6 and Nanog expression could be a
direct outcome of the positive and negative regulative loops
influencing expression of Fgf4, Fgfr2, Nanog, and Gata6. Thus,
the reciprocal gene expression would arise from fluctuating
‘‘noisy’’ expression (Canham et al., 2010; Chambers et al.,
2007; Hayashi et al., 2008; Kalmar et al., 2009) by inducing a
bistable cell fate specification, as shown in other organisms
(Johnston and Desplan, 2010; Stockholm et al., 2010). A
decrease in Fgf4 expression can be observed between the
two-cell stage and the morula stage (Guo et al., 2010) and might
initiate differences in RTK activation and, thus, differences in
Gata6 versus Nanog expression. Alternatively, the initiation of
reciprocal expression could depend on an ‘‘external’’ switch
activated by other factors (transcription, growth factors) orDevelopmental Cell 21, 1005–10from cell-cell interactions as described for the
Hippo pathway in ICM/trophoblast determina-
tion (Nishioka et al., 2009). Recently, two anal-
yses examined the relative roles of two succes-
sive waves of inner cell generation (8- to 16-cell
and 16- to 32-cell stages) in influencing cell fate
(Lanner and Rossant, 2010; Morris et al., 2010;Yamanaka et al., 2010) and came to opposing conclusions.
Posttranscriptional modifications could also play a role in regu-
lating the Nanog/Gata6 balance. It is noteworthy that Gata6/
Nanog reciprocal expression seems to begin at the stage when
ICM/trophoblast determination has just been accomplished.
Our results reveal a three-step mechanism for PrE differentia-
tion (Figure 5): (1) Gata6 is initially directly activated by Fgf4/RTK
signaling from the eight-cell stage (E2.5); (2) between the morula
and early blastocyst stage, a subset of cells maintains higher
levels of Gata6 and reduces the levels of Nanog, which predis-
poses them toward the PrE program; Gata6 expression does
not require direct activation by RTK and is maintained possibly
via an autoregulatory mechanism; and (3) subsequent upregula-
tion of Sox17 and Gata4 then depends on expression of Fgf4
from Nanog-positive epiblast cells to differentiate fully into PrE.
The other subset of cells, engaged toward an epiblast identity,
downregulates Gata6 expression while maintaining high levels
of Nanog. However, cells are only engaged toward a PrE or
epiblast identity but not determined yet because administration
of RTK inhibitors or Fgf4 can change cell identity until at least
E3.75 (Yamanaka et al., 2010).
In conclusion, our multistep model for PrE differentiation high-
lights the importance of continuously changing and reinforcing
interactions between emerging cell types during differentiation.
This has particular relevance for controlling the differentiation
or maintenance of ESCs in vitro because heterogeneous cell
populations would be expected to behave differently than homo-
geneous populations. A full understanding of the mechanisms
regulating epiblast and PrE segregation is also likely to help in
developing a new model for bistable cell fate specification.
EXPERIMENTAL PROCEDURES
Experiments were performed in accordance with French and EU guidelines for
the care and use of laboratory animals.
Embryo Electroporation and Culture
CD1 outbred mice, kept in a 12 hr light cycle, were used for electroporation
experiments. Noon of the vaginal plug was considered as E0.5. Embryos13, December 13, 2011 ª2011 Elsevier Inc. 1011
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(Sigma-Aldrich) at E2.5 before compaction. The zona pellucida was removed
with acid Tyrode solution (Sigma-Aldrich), and embryos were electroporated
in G2 medium (Vitrolife) buffered with HEPES (20 mM) under the following
conditions: four pulses of 30 V and 1.5 ms duration each separated by
100 ms (BTX ECM 830). Embryos were subsequently cultured under paraffin
oil in 10 ml drops for 30–45 hr at 37C, 5% CO2. A pCX vector (Hadjantonakis
et al., 2002) containing H2B-EGFP was electroporated at 50 mg/ml to label
electroporated cells with the pSuper vector (OligoEngine) empty (control) or
carrying the shRNA sequence 50-GACAGTGAGGTGCATATACTTCAAGA
GAGTATATGCACCTCACTGTC-30 targeting Nanog (Ivanova et al., 2006) at
100 mg/ml.
Cell sorting was analyzed counting Gata6-expressing cells remaining inside
and Nanog-expressing cells being at the surface of the ICM. For control
embryos: 11.8% ± 2.7% (n = 120) and 6.3% ± 2.1% (n = 130), respectively.
Nanog Mutant Mice
Homozygous embryos forNanogtm1Yammutation (Mitsui et al., 2003) were pro-
duced by natural matings and genotyped after the staining procedures using
primer IntAS3 (50-CAGAATGCAGACAGGTCTACAGCCCG-30) coupled with
either 50-AATGGGCTGACCGCTTCCTCGTGCTT-30 for the mutant allele or
50-GGCCCAGCTGTGTGCACTCAA-30 for the wild-type allele.
Embryos were staged according to the time of their collection: E2.5 (before
compaction), E2.75 (after compaction), E3.0 (before cavitation), E3.25 (early
expanding blastocyst), E3.5 (ICM:cavity volume = 1:1), E3.75 (ICM volume
less than cavity volume; lineage precursors not fully sorted), E4.0 (sorted
ICM; not implanted), E4.5 (implanted; flat PrE epithelium; no parietal endo-
derm), and E4.75 (beginnings of parietal endoderm migration).
In Vitro Culture and Fgf4 or Inhibitor Treatment
Embryos were flushed in M2 at E2.5, E2.75, or E3.25 and cultured until stages
equivalent to E4.0 or E4.5, with zona pellucida intact in G2 medium. For treat-
ments, the Fgf receptor inhibitor PD173074 (Sigma-Aldrich) at 100 nM and
Mek inhibitor PD0325901 (Axon MedChem) at 500 nM, or recombinant mouse
Fgf4 (5846-F4; R&D Systems) at 1 mg/ml and heparin at 1 mg/ml, were added to
equilibrated G2 medium (Nichols et al., 2009; Yamanaka et al., 2010).
In Situ Labeling
Fluorescent in situ hybridization and immunostaining were performed as
described previously (Chazaud and Rossant, 2006; Chazaud et al., 2006).
Primary antibodies used in this study were: Nanog (21603 [Abcam] and
RCAB0002P-F [Cosmo Bio]), Gata6 (AF1700 [R&D Systems]), Sox17
(AF1924 [R&D Systems]), Gata4 (1237 [Santa Cruz Biotechnology]), GFP
(13970 [Abcam]), Oct4 (19857 [Abcam]), Pdgfra (AF1062 [R&D Systems]),
and Cdx2 (AM392 [BioGenex]). Secondary antibodies coupled with Alexa
488, Cy3, Cy5, and Biotin (Jackson ImmunoResearch) in conjunction with
streptavidin-chromeo 494 (Chromeon) as a fourth fluorochrome were used.
Nuclei were stained with DAPI (Sigma-Aldrich), and apoptotic cells were
labeled using a TUNEL reaction kit (TMR red, 12156792910 [Roche]).
We attempted immunostaining of p-Erk with an antibody from Cell Signaling
Technology (#9101) because it was previously described for this stage (Lin
et al., 2010; Lu et al., 2008); however, the staining appears to be nonspecific
(Figure S4). No signal could be detected with an antibody from Sigma-Aldrich
(M-8159; data not shown). Thus, levels of p-Erk are certainly very low and
transient.
The embryos were scanned with a Leica SP5 laser confocal microscope
and analyzed with ImageJ (NIH). Cell counting was semiautomated with Imaris
(Bitplane) software.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and can be found with this
article online at doi:10.1016/j.devcel.2011.10.019.
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